Suppr超能文献

在大学医院急诊科的药物不良反应发生率、可预防率和因果关系。

Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department.

机构信息

Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Individualized Drug Therapy Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

出版信息

Eur J Clin Pharmacol. 2021 Apr;77(4):643-650. doi: 10.1007/s00228-020-03043-3. Epub 2020 Nov 13.

Abstract

PURPOSE

To investigate the characteristics of ADRs in patients admitting at the emergency room of a tertiary hospital.

METHODS

We collected the patient records of 1600 emergency room visits of a university hospital in 2018. The patient files were studied retrospectively and all possible ADRs were identified and registered. Patient characteristics, drugs associated with ADRs, causality, severity, preventability, and the role of pharmacogenetics were assessed.

RESULTS

There were 125 cases with ADRs, resulting in a 7.8% overall incidence among emergency visits. The incidence was greatest in visits among elderly patients, reaching 14% (men) to 19% (women) in the 80-89 years age group. The most common causative drugs were warfarin, acetylsalicylic acid (ASA), apixaban, and docetaxel, and the most common ADRs were bleedings and neutropenia and/or severe infections. Only two of the cases might have been prevented by pharmacogenetic testing, as advised in Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines.

CONCLUSION

The same ATC classes, antithrombotics and cytostatics, were involved in ADRs causing university clinic hospitalizations as those identified previously in drug-related hospital fatalities. It seems difficult to prevent these events totally, as the treatments are vitally important and their risk-benefit-relationships have been considered thoroughly, and as pharmacogenetic testing could have been useful in only few cases.

摘要

目的

调查三级医院急诊科患者不良反应(ADR)的特征。

方法

我们收集了 2018 年一所大学附属医院 1600 例急诊科就诊患者的病历。对患者病历进行回顾性研究,确定并登记所有可能的 ADR。评估患者特征、与 ADR 相关的药物、因果关系、严重程度、可预防性以及药物遗传学的作用。

结果

共发生 125 例 ADR,总体发生率为 7.8%。在老年患者就诊中发生率最高,80-89 岁年龄组男性为 14%,女性为 19%。最常见的致病药物为华法林、乙酰水杨酸(ASA)、阿哌沙班和多西他赛,最常见的 ADR 为出血和中性粒细胞减少症和/或严重感染。根据临床药物遗传学实施联盟(CPIC)指南,仅两例可能通过药物遗传学检测预防,如建议的那样。

结论

与先前报道的与药物相关的医院死亡病例一样,导致大学诊所住院的 ADR 涉及相同的 ATC 类别,即抗血栓药和细胞毒药物。由于这些治疗至关重要,并且已经对其风险-效益关系进行了充分考虑,因此似乎很难完全预防这些事件,而且药物遗传学检测在少数情况下可能有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/577c/7935812/a48869aa6ccc/228_2020_3043_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验